Debt-to-equity of Finch Therapeutics Group, Inc. from 30 Sep 2021 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Finch Therapeutics Group, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Jun 2024.
  • Finch Therapeutics Group, Inc. Debt-to-equity for the quarter ending 30 Jun 2024 was 157%, a 100% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Finch Therapeutics Group, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 157% +78% +100% 30 Jun 2024
Q1 2024 142% +82% +134% 31 Mar 2024
Q4 2023 136% +95% +231% 31 Dec 2023
Q3 2023 101% +73% +263% 30 Sep 2023
Q2 2023 79% +61% +359% 30 Jun 2023
Q1 2023 61% +51% +506% 31 Mar 2023
Q4 2022 41% +32% +331% 31 Dec 2022
Q3 2022 28% +13% +83% 30 Sep 2022
Q2 2022 17% 30 Jun 2022
Q1 2022 10% 31 Mar 2022
Q4 2021 9.6% 31 Dec 2021
Q3 2021 15% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.